SurModics to Webcast Third Quarter 2012 Earnings Conference Call on August 1st

Wed, 07/25/2012 - 5:06pm
The Associated Press

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jul 25, 2012--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its third quarter 2012 conference call on Wednesday, August 1, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afternoon.

Gary Maharaj, chief executive officer, and Tim Arens, vice president of finance and interim chief financial officer, will recap the third quarter 2012 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company’s website at the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 7:00 p.m. CT on Wednesday, August 1, until 7:00 p.m. CT on Wednesday, August 8 and can be accessed by dialing 800-406-7325 and entering conference call ID passcode 4556791. In addition, the conference call audio will be archived on the Company’s website following the call.

About SurModics, Inc. SurModics’ mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.

CONTACT: SurModics, Inc.

Timothy J. Arens, Vice President of Finance and interim Chief Financial Officer 952-500-7000 KEYWORD: UNITED STATES NORTH AMERICA MINNESOTA INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY MEDICAL DEVICES MANUFACTURING CHEMICALS/PLASTICS SOURCE: SurModics, Inc. Copyright Business Wire 2012 PUB: 07/25/2012 05:06 PM/DISC: 07/25/2012 05:06 PM


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.